If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.66    0.00 (0.00%)
Bid:
2.62
Ask:
2.70
Spread: 0.08 (3.053%)
Market Cap: £14.43m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Issue of Employee Share Options

7 Oct 2024 07:00

RNS Number : 0906H
Valereum PLC
07 October 2024
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")

 

07/10/2024

 

Valereum Plc

("Valereum" or the "Company")

 

Issue of Employee Share Options

To create alignment across the senior management team Valereum Plc announces that it has awarded share options ("Options") over a total of 4,510,000 ordinary shares to the Head of VLRM Markets and Head of VLRM Technology Verticals. The Options are tax-advantaged options that require a minimum holding period of 2 years from the date of being granted to qualify for the full tax advantages and are subject to a lock-in period of 1 year from the date of issue of the Options. They are exercisable at a cost of £0.001 per share, expire after 10 years and will be forfeited in the event the employees leave the Company.

The awards ensure the senior executive team are now in line (excluding the CEO and Chairman). We anticipate no further awards being made to existing team members outside of the approved annual remuneration scheme, as announced in May this year.

Chairman, James Formolli, commented:

"I firmly believe that as we ensure our team is fully motivated and incentivised to develop Valereum Plc, they must be in line with the interests of our shareholders. This alignment of goals will benefit all involved as we move forward together.

I'm excited about the rest of 2024 and what 2025 holds for Valereum Plc, as we continue building on momentum and execute our strategic vision".

For further information, please contact as follows:

Enquiries:

Valereum Plc

James Formolli, Chairman

Tel: +44 7938 767319

 

Stanford Capital Partners

Bob Pountney

Patrick Claridge

Tel: 023 3650 3650

 

First Sentinel Corporate Finance

AQSE Corporate Adviser

Brian Stockbridge

Tel: +44 20 3855 5551

 

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For more information, please visit the Company's website at www.vlrm.com

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Adrian Hogg

2. Daryl Mcfarlane

2.

Reason for the Notification

a)

Position/status

1. Head of VLRM Markets

2. Head of VLRM Technology Verticals

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 

Price

Volume

1. £0.001

2. £0.001

1. 2,510,000

2. 2,000,000

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

1. 01 October 2024

2. 01 October 2024

f)

Place of the Transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFSWEDMELSEDS
Date   Source Headline
3rd Jul 20261:12 pmRNS-RValereum Vox Issue 6 Published
30th Jun 20266:15 pmRNSResults for the year ended 31 December 2025
19th Jun 20261:00 pmRNS-RValereum Vox Issue 5 Published
5th Jun 20264:32 pmRNS-RValereum Vox Issue 4 Published
1st Jun 20267:00 amRNSHolding(s) in Company
22nd May 20263:00 pmRNS-RValereum Vox Issue 3 Published
15th May 20267:00 amRNSPlacing and Subscription Raising £1,050,000
11th May 20264:10 pmRNS-RValereum Vox Issue 2 Published
23rd Apr 20261:45 pmRNS-RLaunch of new blog, Valereum Vox
22nd Apr 20267:00 amRNSDefinitive Agreement with QGP
21st Apr 20267:00 amRNSSettlement Agreement with Blubird
16th Apr 20267:00 amRNSDefinitive Agreement Update
10th Apr 20262:48 pmRNSReplacement - Coupon Payment Received
10th Apr 20262:07 pmRNSCoupon Payment Received
9th Apr 202611:32 amRNSShare Options and PDMR Dealings
31st Mar 20261:46 pmRNSInvestor Meeting
31st Mar 20267:31 amRNSProposed Strategic Integration and Coupon Payment
4th Mar 20267:00 amRNSOTCQB Approval
27th Feb 202610:53 amRNSVLRM Markets Organisational Update
25th Feb 20267:00 amRNSOption Agreement to Cancel 2 Million Warrants
16th Feb 20267:00 amRNSDirectorate Changes
16th Feb 20267:00 amRNSSigning of MoU with Integra Foundation
9th Feb 20267:00 amRNSSigning of MoU with RWA.io & Defactor
6th Feb 20267:00 amRNSChanges to Board of Directors
30th Jan 20262:00 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSSigning of MoU and Exercise of Warrants
27th Jan 20263:50 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSForward Strategy Update
21st Jan 20267:00 amRNSAgreement and Lifting of Suspension
22nd Dec 20257:00 amRNSContract
22nd Dec 20257:00 amRNSContract
17th Dec 20257:00 amRNSResignation of Corporate Adviser and Suspension
4th Dec 202510:56 amRNS-ROTC Application
2nd Dec 202510:34 amRNSUpdate on Capital Raise
25th Nov 20257:00 amRNSAgreement to Raise Capital
21st Nov 20257:00 amRNSExercise of Warrants
17th Nov 20257:00 amRNSCompletion of Subscription
14th Nov 20257:00 amRNSDeployment of DigiShares’ Tokenisation Platform
27th Oct 20257:00 amRNS-RCOINGT to List on VLRM Markets
10th Oct 20257:00 amRNSSubscription to Raise £600,000
7th Oct 20257:00 amRNSVLRM Markets’ Post Launch Update
1st Oct 20259:00 amRNSOption Agreement to Cancel 2m Warrants
25th Sep 20257:00 amRNSValereum Advances GATE Token Strategy
24th Sep 20254:47 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSInterim Results
19th Sep 20257:00 amRNS-RUpdate on Strategy Implementation
10th Sep 20257:00 amRNS-RVLRM to Co-host Exclusive Side Event at TOKEN2049
4th Sep 20257:00 amRNS-RCrypto and Multi Currency Payroll Solution
20th Aug 20251:00 pmRNS-RStrategic Collaboration with ZIGChain & DigiShares
18th Aug 20257:00 amRNS-RIndirect Investee Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.